ArticleOncoimmunology

Th17 cell-derived IL-17A promoted tumor progression via STAT3/NF-κB/Notch1 signaling in non-small cell lung cancer.

Ruirui Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.